Non-Invasive Preeclampsia Screening and Biobank
NCT06643741 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 6550
Last updated 2026-01-23
Summary
Women pregnant between 11-14 weeks gestation will be enrolled with blood samples collected to evaluate for preeclampsia.
Conditions
- Preeclampsia (PE)
Sponsors & Collaborators
-
Rutgers Robert Wood Johnson Medical School
collaborator OTHER -
Laboratory Corporation of America
collaborator INDUSTRY -
Sequenom, Inc.
lead INDUSTRY
Principal Investigators
-
Emily Rosenfeld, DO · Rutgers Robert Wood Johnson Medical School
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-02-02
- Primary Completion
- 2026-06-01
- Completion
- 2026-07-01
Countries
- United States
Study Locations
More Related Trials
-
Molecular Study of the Maternal-fetal Interface in Preeclampsia.
NCT06232668 ·Status: RECRUITING
-
Pulmonary Embolism in Pregnancy: Biomarkers and Clinical Predictive Models
NCT02709174 ·Status: COMPLETED
-
Predicting Late-onset Preeclampsia at 10-14 Weeks of Pregnancy
NCT04075708 ·Status: COMPLETED
-
Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers
NCT02808494 ·Status: COMPLETED
-
Study to Determine if Serum BNP Levels Are Elevated in Pregnant Women With Pre-Eclampsia
NCT00533871 ·Status: COMPLETED
-
What Are the Predictive Factors for Preeclampsia in Oocyte Recipients? - PREROVE
NCT03668184 ·Status: COMPLETED
-
Maternal Serum Markers Predicting Preeclampsia At Early Gestations
NCT05131282 ·Status: COMPLETED
-
Non-invasive Test to Detect Intra-amniotic Infection in Women With Preterm Labor and Intact Amniotic Membranes
NCT00700219 ·Status: UNKNOWN
-
Utilization of Somatic Tissue Oxygen Saturation Monitoring in Pregnant Women
NCT03196141 ·Status: WITHDRAWN ·Phase: NA
-
Goal-Directed Therapy in Pregnant Women at High Risk of Developing Preeclampsia
NCT01351428 ·Status: COMPLETED ·Phase: NA
-
IMproved PRegnancy Outcome by Early Detection
NCT01891240 ·Status: UNKNOWN
-
MorbiMortality Amelioration in Preeclamptic Primiparas Study. MoMA Pre Prim Study
NCT00763672 ·Status: COMPLETED ·Phase: NA
-
Prediction of Preeclampsia by Comprehensive Markers.
NCT03665623 ·Status: COMPLETED
-
Collection of Whole Blood Specimens in Pregnant Women
NCT03590678 ·Status: COMPLETED
-
A Study Collecting Blood Samples From Pregnant Women to Aid in the Development of a Noninvasive Prenatal Test
NCT03620110 ·Status: COMPLETED
-
PREPARE, Prematurity Reduction by Pre-eclampsia Care
NCT03073317 ·Status: COMPLETED ·Phase: NA
-
Chronic Remote Ischemic Preconditioning as a Complement to Conventional Prenatal Care for Preeclampsia
NCT05564988 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Comparison of Random Spot Urine Protein:Creatinine Ratio to 24-Hour Timed Urine Protein Collection in the Evaluation of Preeclampsia
NCT01447290 ·Status: COMPLETED
-
Novel Biomarkers of Preeclampsia, Aquaporin, Fatty Acid, and S110B
NCT03567551 ·Status: COMPLETED
-
Validate Non-invasive Prenatal Tests for the Detection of Chromosomal Abnormalities
NCT05618431 ·Status: RECRUITING ·Phase: NA
-
Biobank on Prematurity, Preeclampsia and Other Pregnancy Complications
NCT02744365 ·Status: RECRUITING
-
Validation of the MaiRa Preeclampsia Test for Screening Early/Late Preeclampsia in First and Second Trimesters
NCT06716242 ·Status: RECRUITING
-
COVID-19 International Drug Pregnancy Registry
NCT05013632 ·Status: RECRUITING
-
A Study to Evaluate the Use of Placenta Protein 13 (PP13) in the First Trimester of Pregnancy as a Diagnostic Aiding Tool in the Assessment of the Risk for Developing Preeclampsia in Women With Low and Unknown Risk
NCT00572793 ·Status: COMPLETED
-
A Comparison of BNP Levels Using the Nexfin Device in Healthy Pregnant and Preeclamptic Women
NCT02527018 ·Status: COMPLETED